A poorly differentiated tumor, what chemo is recommended

According to the NCCN Guidelines, for poorly differentiated neuroendocrine carcinomas (NECs), the recommended chemotherapy options include:

1. Cisplatin and etoposide (Etopophos) OR
2. Carboplatin and etoposide (Etopophos)

These may be given:

• As chemotherapy alone
• Combined with radiation therapy (chemoradiation)
• Before or after surgery in some cases

However, I want to note that treatment recommendations can vary based on several important factors:

• Whether your tumor is resectable (can be surgically removed)
• If it's localized or has spread
• Your overall health status
• Other specific characteristics of your tumor

The NCCN Guidelines recommend monitoring during and after treatment with:

• Follow-up tests every 6-16 weeks
• Regular physical exams
• Imaging scans (chest CT and abdominal/pelvic MRI or CT)

Important note: While I can provide this general information from the NCCN Guidelines, your oncologist will determine the best specific chemotherapy regimen for your situation. They may recommend different combinations based on your particular case and the most current treatment options available.

Please discuss these options with your healthcare team, as they can provide personalized recommendations based on your specific situation and medical history.

Sources:

• NCCN Guidelines for Patients: Neuroendocrine Tumors (2022)
• NCCN Guidelines sections on poorly differentiated carcinomas and treatment protocols